The effect of sodium-glucose linked transporter 2 inhibitor and glucagon-like peptide-1 receptor agonist on weight and blood pressure control in an obese diabetic patient: a case report

Obesity and diabetes are two closely related and often co-occurring clinical conditions that are difficult to treat and full of uncertainties. Moreover, they are often accompanied by another disease that is just as difficult to treat: hypertension. Although the picture may seem complex, pessimistic, and requiring a lot of medication, it is possible to develop a holistic strategy. With the case we have presented, we would like to share our treatment plan focused on the treatment of diabetes and its results and draw attention to the effects of antidiabetic therapies on weight loss and blood pressure control.